Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue-plasminogen activator
- 31 July 1992
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 20 (1), 228-235
- https://doi.org/10.1016/0735-1097(92)90164-i
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Streptokinase Inhibits Acute Platelet Thrombus Formation in Stenosed Dog Coronary ArteriesPlatelets, 1991
- Pharmacokinetics and Coronary Thrombolytic Properties of Two Human Tissue-Type Plasminogen Activator Variants Lacking the Finger-Like, Growth Factor-Like, and First Kringle Domains (Amino Acids 6–173) in a Canine ModelJournal of Cardiovascular Pharmacology, 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.JCI Insight, 1990
- Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarctionJournal of the American College of Cardiology, 1989
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysisJournal of the American College of Cardiology, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 1985
- Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?Circulation, 1982
- Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmiasNature, 1981